SLC5A5 and thyroid cancer: Previous research has demonstrated that SCFA, particularly butyric acid, inhibits histone deacetylase (HDAC) and activates NIS re-expression in thyroid cancer cells, leading to redifferentiation and enhanced iodine uptake (73).